1. Home
  2. QRTEA vs LCTX Comparison

QRTEA vs LCTX Comparison

Compare QRTEA & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QRTEA
  • LCTX
  • Stock Information
  • Founded
  • QRTEA 1991
  • LCTX 1990
  • Country
  • QRTEA United States
  • LCTX United States
  • Employees
  • QRTEA 20300
  • LCTX N/A
  • Industry
  • QRTEA Catalog/Specialty Distribution
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • QRTEA Consumer Discretionary
  • LCTX Health Care
  • Exchange
  • QRTEA Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • QRTEA 146.0M
  • LCTX 166.3M
  • IPO Year
  • QRTEA N/A
  • LCTX N/A
  • Fundamental
  • Price
  • QRTEA $0.37
  • LCTX $0.60
  • Analyst Decision
  • QRTEA
  • LCTX Strong Buy
  • Analyst Count
  • QRTEA 0
  • LCTX 4
  • Target Price
  • QRTEA N/A
  • LCTX $4.75
  • AVG Volume (30 Days)
  • QRTEA 3.0M
  • LCTX 909.4K
  • Earning Date
  • QRTEA 11-07-2024
  • LCTX 11-14-2024
  • Dividend Yield
  • QRTEA N/A
  • LCTX N/A
  • EPS Growth
  • QRTEA N/A
  • LCTX N/A
  • EPS
  • QRTEA N/A
  • LCTX N/A
  • Revenue
  • QRTEA $10,236,000,000.00
  • LCTX $8,719,000.00
  • Revenue This Year
  • QRTEA N/A
  • LCTX N/A
  • Revenue Next Year
  • QRTEA N/A
  • LCTX $123.52
  • P/E Ratio
  • QRTEA N/A
  • LCTX N/A
  • Revenue Growth
  • QRTEA N/A
  • LCTX N/A
  • 52 Week Low
  • QRTEA $0.35
  • LCTX $0.56
  • 52 Week High
  • QRTEA $1.80
  • LCTX $1.61
  • Technical
  • Relative Strength Index (RSI)
  • QRTEA 26.17
  • LCTX 26.43
  • Support Level
  • QRTEA $0.43
  • LCTX $0.80
  • Resistance Level
  • QRTEA $0.47
  • LCTX $0.97
  • Average True Range (ATR)
  • QRTEA 0.04
  • LCTX 0.07
  • MACD
  • QRTEA -0.01
  • LCTX -0.03
  • Stochastic Oscillator
  • QRTEA 8.18
  • LCTX 9.45

About QRTEA Qurate Retail Inc. Series A

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: